Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma.
about
Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer TherapyCancer stem cells--important players in tumor therapy resistanceEstimating dose painting effects in radiotherapy: a mathematical modelHoloclone forming cells from pancreatic cancer cells enrich tumor initiating cells and represent a novel model for study of cancer stem cellsA novel synthetic smoothened antagonist transiently inhibits pancreatic adenocarcinoma xenografts in a mouse modelAmelioration of cancer stem cells in macrophage colony stimulating factor-expressing U87MG-human glioblastoma upon 5-fluorouracil therapyChemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like CellsA simple biological imaging system for detecting viable human circulating tumor cells.Highly automated nano-LC/MS-based approach for thousand cell-scale quantification of side chain-hydroxylated oxysterols.Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302.Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.Hijacking HES1: how tumors co-opt the anti-differentiation strategies of quiescent cells.Endothelium originated from colorectal cancer stem cells constitute cancer blood vesselsTargeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancerNanoparticle labeling identifies slow cycling human endometrial stromal cellsEvidence for label-retaining tumour-initiating cells in human glioblastomaOvercoming drug resistance in pancreatic cancer.Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer.Evaluation of stem-like side population cells in a recurrent nasopharyngeal carcinoma cell line.Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung CancerContribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progressionCellular plasticity regulated cancer stem cell niche: a possible new mechanism of chemoresistanceBlockade of dual-specificity phosphatase 28 decreases chemo-resistance and migration in human pancreatic cancer cells.Histological Characterization of the Tumorigenic "Peri-Necrotic Niche" Harboring Quiescent Stem-Like Tumor Cells in GlioblastomaThe role of epithelial-mesenchymal transition in pancreatic cancerStem cells from trabecular meshwork home to TM tissue in vivo.Membranous and cytoplasmic expression of epidermal growth factor receptor in metastatic pancreatic ductal adenocarcinoma.Identification and isolation of slow-dividing cells in human glioblastoma using carboxy fluorescein succinimidyl ester (CFSE).Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells.Cancer stem cell theory: therapeutic implications for nanomedicine.Cancer stem cells and chemoresistance: The smartest survives the raidEfficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells.Marker-independent method for isolating slow-dividing cancer stem cells in human glioblastoma.Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic TumorsBulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCsLabel-retaining assay enriches tumor-initiating cells in glioblastoma spheres cultivated in serum-free medium.Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cellsCancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies.
P2860
Q26740207-20C2B346-04F4-403B-BCA7-C6E5D1E2BCDCQ26823015-02766071-1FDE-4D0E-BDBB-EB01E20B8602Q27321048-053CCC83-6A87-410C-8F14-DEBDD858400CQ28476426-FB9DDD67-98A1-4B8E-9B8F-B55AE19C2781Q28478580-55B6BCFD-FC90-422D-803F-2916F97131BAQ28538154-11C54024-C75F-4E8A-8FA1-CC6AC2939A50Q28547244-4FBA89AF-4277-4ED1-8D45-609D3816BF57Q30490534-EAEB2606-0D86-4825-A071-FB20F8FC23FDQ30582043-50EB8D1A-F017-4BCE-92AD-7AB9953034CFQ30826843-E681DB69-6124-4238-AA19-94F388F94924Q33778101-5CF83A89-3328-4BB9-8FFB-E383F42A6594Q33788010-5A026271-84C1-42D1-BC7F-992B67CB9456Q33831060-98EFFF02-B2E7-4CD3-92A8-9B5CFA325D43Q33873312-C0DDD8B2-99F4-4F37-9E2E-208921DCDFEEQ34420393-9B38884D-82DC-4908-8A1A-9E7A620F6122Q34486401-E72402F0-BE13-43B6-BC16-3D5D641B28ACQ34505099-65EB8951-E88C-437B-A012-A6B575ECC638Q34992194-F6D5A775-FBFC-4258-B650-51BCDCC138C1Q35036615-FABA242C-1F4D-4CB3-9A78-110920564E0AQ35038324-A4A44110-6E8E-4E6B-8FA7-E5B400AB3BB9Q35333542-F9CB90F2-80DC-4703-B500-2E56735FAF54Q35744111-A4BA4374-5C9C-44F1-A38E-4F594414FB1CQ35754181-DC4E67FA-5501-4754-93E4-FE19076DA70AQ35828103-B130D28A-9CA9-4AA6-B0E9-B9162E8FBB3DQ35891112-744D9FB6-93B4-4732-8F21-0C3CEE68EAFBQ35901357-B2EE6763-C3EF-40EA-8F2B-55D8F995DAC3Q36097197-D6E283FE-3B7F-4482-83F2-AE9C39AAE38DQ36159545-77261F07-F99E-47E4-9439-D6B9BD982FA2Q36224439-33AD1E5D-AFB3-4F04-AD9A-E7B4F0FE2435Q36304506-D07C94A2-6DBE-49A2-BCF9-B3DE435B8424Q36429978-8680B50A-CDB3-4A2E-9186-41DA78F91B28Q36659443-0C7A7B0C-213D-4D8A-B973-4E308C3C14C5Q36730432-BFBAFC36-A17F-4A32-AB63-CDDCBAD163CEQ36792380-DD1D978F-B53E-4D6E-8B45-02446C876681Q36945952-0B91FE85-8487-4D8F-8449-D50F43E6BD57Q37017121-A523B010-74F8-4480-A2EA-FB5608674895Q37091938-339F6F38-1564-4FBE-9FDE-F1BDBB3EFD00Q37106630-1A36940C-2BB5-4C3B-AFA3-5F72DB0830CFQ37178822-EE323B50-7145-408D-887C-44B6315488D0Q37299578-2C26AA21-FF1E-4DF2-AD1D-6D329ED54D33
P2860
Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization and functiona ...... on in pancreas adenocarcinoma.
@en
Characterization and functiona ...... on in pancreas adenocarcinoma.
@nl
type
label
Characterization and functiona ...... on in pancreas adenocarcinoma.
@en
Characterization and functiona ...... on in pancreas adenocarcinoma.
@nl
prefLabel
Characterization and functiona ...... on in pancreas adenocarcinoma.
@en
Characterization and functiona ...... on in pancreas adenocarcinoma.
@nl
P2860
P1476
Characterization and functiona ...... on in pancreas adenocarcinoma.
@en
P2093
Jennifer L Dembinski
Stefan Krauss
P2860
P2888
P304
P356
10.1007/S10585-009-9260-0
P577
2009-05-07T00:00:00Z